ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
AGN Algernon Pharmaceuticals Inc
- 0.075
- +0.005+7.14%
15min DelayMarket Closed Dec 13 15:59 ET
2.05MMarket Cap-2.21P/E (TTM)
0.075High0.070Low65.38KVolume0.070Open0.070Pre Close4.58KTurnover0.16552wk High0.27%Turnover Ratio27.30MShares0.06052wk Low-0.034EPS TTM1.79MFloat Cap27.500Historical HighLossP/E (Static)23.91MShs Float0.050Historical Low-0.45EPS LYR7.14%Amplitude--Dividend TTM1.04P/B1Lot Size--Div YieldTTM
Algernon Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -143.65%-1.79M | 45.70%-239.05K | 93.53%-52.24K | 12.35%-2.55M | 61.08%-572.71K | 21.18%-732.94K | 48.22%-440.22K | -338.14%-807.14K | 62.77%-2.91M | -80.72%-1.47M |
| Net income from continuing operations | 228.09%1.44M | 19.53%-1M | 72.26%-521.55K | -12.01%-6.78M | -13.95%-2.53M | -40.80%-1.13M | 32.05%-1.25M | -56.60%-1.88M | 21.72%-6.05M | -822.80%-2.22M |
| Operating gains losses | -14,511.01%-1.91M | -129.18%-6.41K | -56.82%10.82K | 263.89%73.95K | 162.81%13.65K | 35,770.27%13.27K | 255.08%21.97K | 370.68%25.05K | -248.48%-45.12K | 77.21%-21.73K |
| Depreciation and amortization | -52.58%6.09K | -39.04%7.64K | -36.46%7.43K | 44.26%50.4K | -53.00%13.34K | 552.70%12.83K | 173.23%12.54K | --11.69K | --34.94K | --28.38K |
| Asset impairment expenditure | ---- | ---- | ---- | 4,125.19%1.54M | ---- | ---- | ---- | ---- | --36.48K | ---- |
| Remuneration paid in stock | -68.57%61.01K | -60.46%156.61K | -88.43%69.04K | 136.76%1.26M | -69.50%69.8K | 1,256.22%194.1K | 37.70%396.12K | --596.8K | -35.84%530.84K | 298.69%228.86K |
| Other non cashItems | ---- | ---- | ---- | --40K | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -894.81%-1.38M | 61.17%607.01K | -13.05%382.03K | -51.03%1.27M | -41.81%275.59K | 219.59%174.15K | -46.79%376.64K | -71.63%439.34K | 532.28%2.58M | 305.05%473.58K |
| -Change in receivables | 17.94%21.92K | -113.79%-16.69K | -81.98%81.72K | -64.83%567.8K | 84.60%-25.22K | 151.42%18.58K | 178.94%121.01K | -76.96%453.43K | 240.31%1.61M | -139.81%-163.71K |
| -Change in prepaid assets | -163.42%-52.34K | -93.21%17.31K | -74.43%85.45K | 215.37%634.37K | 93.55%-37.24K | 1,582.20%82.53K | 377.09%254.93K | 1,737.27%334.15K | -398.61%-549.84K | -358.31%-577.3K |
| -Change in payables and accrued expense | -1,953.40%-1.35M | 86,280.48%606.39K | 153.44%186.11K | -95.82%63.54K | -72.17%338.05K | 170.28%73.04K | -99.91%702 | 12.60%-348.25K | 312.28%1.52M | 240.30%1.21M |
| -Change in other working capital | --0 | --0 | --28.75K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -143.65%-1.79M | 45.70%-239.05K | 93.53%-52.24K | 12.35%-2.55M | 61.08%-572.71K | 21.18%-732.94K | 48.22%-440.22K | -338.14%-807.14K | 62.77%-2.91M | -80.72%-1.47M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 8,640.70%2.31M | -152.13%-23.12K | 0 | 58.85%-59.5K | 88.63%-5.58K | -151.17%-27.01K | 79.50%-9.17K | 55.71%-17.74K | -16.20%-144.61K | -372.51%-49.07K |
| Net intangibles purchas and sale | 10,038.86%2.68M | -152.13%-23.12K | --0 | 58.85%-59.5K | 88.63%-5.58K | -151.17%-27.01K | 79.50%-9.17K | 55.71%-17.74K | -16.20%-144.61K | -372.51%-49.07K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 8,640.70%2.31M | -152.13%-23.12K | --0 | 58.85%-59.5K | 88.63%-5.58K | -151.17%-27.01K | 79.50%-9.17K | 55.71%-17.74K | -16.20%-144.61K | -372.51%-49.07K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.23%7.5K | 1,645.46%265.57K | 0 | -35.34%1.33M | -86.90%269.17K | 974K | -17.18K | 102.93K | -51.59%2.06M | 3,725.00%2.06M |
| Net common stock issuance | --0 | ---- | ---- | -40.35%1.23M | -91.86%167.25K | --1.05M | ---- | ---- | -23.70%2.06M | 5,037.81%2.06M |
| Proceeds from stock option exercised by employees | --7.5K | --0 | --0 | --102.93K | --0 | --0 | --0 | --102.93K | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---80.2K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.23%7.5K | 1,645.46%265.57K | --0 | -35.34%1.33M | -86.90%269.17K | --974K | ---17.18K | --102.93K | -51.59%2.06M | 3,725.00%2.06M |
| Net cash flow | ||||||||||
| Beginning cash position | -65.42%76.28K | -89.25%74.17K | -91.12%125.09K | -41.58%1.41M | -50.25%434.23K | -87.84%220.59K | -74.43%689.7K | -41.58%1.41M | -60.61%2.41M | -73.45%872.84K |
| Current changes in cash | 147.05%528.8K | 100.73%3.41K | 92.76%-52.24K | -28.07%-1.28M | -157.84%-309.12K | 122.75%214.05K | 47.86%-466.58K | -341.55%-721.95K | 72.93%-1M | 160.64%534.44K |
| Effect of exchange rate changes | 1,218.09%4.45K | 48.88%-1.3K | -57.75%1.33K | 140.89%175 | -102.12%-26 | -278.48%-398 | -122.83%-2.54K | 124.14%3.14K | 94.91%-428 | -73.04%1.23K |
| End cash Position | 40.37%609.52K | -65.42%76.28K | -89.25%74.17K | -91.12%125.09K | -91.12%125.09K | -50.25%434.23K | -87.84%220.59K | -74.43%689.7K | -41.58%1.41M | -41.58%1.41M |
| Free cash from | -138.89%-1.82M | 41.66%-262.17K | 93.67%-52.24K | 14.55%-2.61M | 61.97%-578.29K | 19.21%-759.95K | 49.78%-449.39K | -375.99%-824.88K | 61.53%-3.06M | -84.39%-1.52M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.